Results 151 to 160 of about 4,576,038 (327)

Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study

HIV Medicine, EarlyView.
Abstract Background Stigma remains a major barrier to accessing HIV care. We analysed the association between stigma and failed pillbox return, and described factors associated with stigma among adults living with HIV in rural Tanzania. Methods From the Kilombero and Ulanga Antiretroviral Cohort we included newly diagnosed adults ≥15 years enrolled ...
Robert Ndege, James Okuma, Bernard Kivuma, Raphael Magnolini, Leila Samson, Ezekiel Luoga, Elizabeth Senkoro, Olivia Kitau, Fiona Vanobberghen, Daniel H. Paris, Maja Weisser, on behalf of the KIULARCO Study Group   +11 more
wiley   +1 more source

Adherence to Antiretroviral Therapy and Associated Factors among People Living with HIV/AIDS in Hara Town and Its Surroundings, North-Eastern Ethiopia: A Cross-Sectional Study

, 1970
Tesfaye Aychew Legesse, Melese Abate Reta   +1 more
openalex   +2 more sources

Functional T Cell Reconstitution and Human Immunodeficiency Virus–1–Specific Cell‐Mediated Immunity during Highly Active Antiretroviral Therapy [PDF]

, 1999
Oscar Pontesilli, Susana R. Kerkhof‐Garde, Daan W. Notermans, Norbert A. Foudraine, Marijke Roos, Michèl R. Klein, Sven A. Danner, Joep M. A. Lange, Frank Miedema   +8 more
openalex   +1 more source

Natural occurrence of drug resistance mutations to the HIV‐1 capsid inhibitor lenacapavir

HIV Medicine, EarlyView.
Abstract Aims Lenacapavir (LEN) is a first‐in‐class HIV‐1 capsid inhibitor. We investigated the natural occurrence of LEN drug resistance mutations (DRM) in HIV‐1 sequences from LEN treatment‐naïve individuals. Methods We analysed all available HIV‐1 capsid sequences (n = 21 646) from individuals never exposed to LEN from the Los Alamos National ...
A. Weibull Wärnberg, R. Ceña‐Diez, A. Sönnerborg, M. A. A. van de Klundert   +3 more
wiley   +1 more source

Use of dual antiretroviral therapy in individuals with different serological patterns for hepatitis B: What are the risks? What are the clinical implications? [PDF]

HIV Med
HIV Medicine, Volume 26, Issue 8, Page 1317-1320, August 2025.
Kaya A, Benke D, Swan T, Breitschwerdt S, Wasmuth JC, Boesecke C, Rockstroh JK.   +6 more
europepmc   +2 more sources

Antiretroviral Therapy Is Associated with a Decrease in Unintegrated HIV-1 DNA in Pediatric Patients

, 1994
Richard Donovan, Charlene E. Bush, Susan M. Smereck, Ellen Moore, Flossie Cohen, Louis D. Saravolatz   +5 more
openalex   +1 more source

Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. [PDF]

, 1995
Oren J. Cohen, G Pantaleo, Mark Holodniy, S. Schnittman, Manette T. Niu, Cecilia Graziosi, George N. Pavlakis, Jacob Lalezari, John Bartlett, Roy T. Steigbigel   +9 more
openalex   +1 more source

Morbidity and risk factors of COVID‐19 in people with HIV‐1 in Europe: A combined observational cohort and nested case–control study

HIV Medicine, EarlyView.
Abstract Objective To study the COVID‐19 disease course in people living with HIV (PLWH) based on meaningful case numbers, information about comorbidities, antiretroviral and COVID‐19 treatment and HIV disease‐related variables. Methods Multi‐centre, observational, retrospective study of people living with HIV with COVID‐19 matched to HIV‐uninfected ...
Georg M. N. Behrens, Lambert Assoumou, Stephane De Wit, Rona MacDonald, Nathalie de Castro, Casper Rokx, Holly Middleditch, Margaret Johnson, Jose Luis Casado, Jose Ramon Arribas, Jose‐Ramon Blanco, Carl Fletcher, Caroline Eteve‐Pitsaer, Aliou Baldé, Anton Pozniak, Esteban Martinez, on behalf of the HIV CoCo Study Group, Arkaitz Imaz, David Rial Crestelo, Mar Masia Canuto, Jose Luis Blanco Arevalo, Alberto Díaz De Santiago, Pere Domingo Pedrol, Patrick Philibert, Jean‐Michel Molina, Frank Post, Ade Apoola, Chloe Orkin, Mark Gompels, Margherita Bracchi, Julie Fox, Marta Vasylyev   +31 more
wiley   +1 more source

Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics

HIV Medicine, EarlyView.
Abstract Objectives Long‐acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real‐world data in East Asia remain scarce. This study aims to evaluate the impact of CAB+RPV in people with HIV in Japan, focusing on virological outcomes, treatment continuation and inflammatory markers, providing valuable insight ...
Eisuke Adachi, Rumi Minami, Michinori Shirano, Hideta Nakamura, Kazuaki Fukushima, Mayumi Imahashi, Ryoko Sekiya, Yusuke Yoshino, Toshibumi Taniguchi, J‐HIV RWD Collaborative Database Team, Takashi Muramatsu, Yuji Hirai   +11 more
wiley   +1 more source

Co‐Occurrence of HIV‐Susceptibility and ‐Protective HLA Alleles Is a Possible Contributor to the Development of Primary HIV‐Associated Thrombocytopenia (PHAT): A Cross‐Sectional Study

International Journal of Immunogenetics, EarlyView.
ABSTRACT Primary HIV‐associated thrombocytopenia (PHAT) is an isolated thrombocytopenia in HIV‐positive individuals in the absence of secondary causes. The presence of certain Human Leukocyte Antigens (HLA) has been linked to individuals’ immune response to HIV and the development of immune‐mediated thrombocytopenic disorders.
Walter J Janse van Rensburg, Anne‐Cecilia van Marle, Lomari Geertsema   +2 more
wiley   +1 more source